Ahmed Hamdy MD - 14 Dec 2022 Form 4 Insider Report for Vincerx Pharma, Inc. (VINC)

Role
Chief Executive Officer, Director
Signature
/s/ Dr. Ahmed M. Hamdy
Issuer symbol
VINC
Transactions as of
14 Dec 2022
Net transactions value
+$30,538
Form type
4
Filing time
14 Dec 2022, 20:22:15 UTC
Previous filing
17 Nov 2022
Next filing
16 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VINC Common Stock Purchase $30,538 +35,280 +92% $0.8656 73,760 14 Dec 2022 The Hamdy Family Trust dated 10/7/2015 F1
holding VINC Common Stock 1,618,199 14 Dec 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a weighted average purchase price. Actual purchase prices ranged from $0.829 to $0.87 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares purchased within the range indicated.